Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
Kidney International|July 16, 2004
Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stressJenny J Zhang, Grant Bledsoe, Kazuo Kato, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 14, 2009
Intermedin is a new angiogenic growth factorRobert S Smith, Lin Gao, Grant Bledsoe, et al.
Journal of Cardiac Failure|September 11, 2007
Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarctionYu-Yu Yao, Hang Yin, Bo Shen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 3, 2008
Role of kallistatin in prevention of cardiac remodeling after chronic myocardial infarctionLin Gao, Hang Yin, Robert S Smith, et al.
Hypertension (Dallas, Tex. : 1979)|April 9, 2008
Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stressBo Shen, Makoto Hagiwara, Yu-Yu Yao, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 9, 2002
Adrenomedullin improves cardiac function and prevents renal damage in streptozotocin-induced diabetic ratsEric Dobrzynski, David Montanari, Jun Agata, et al.
Experimental Neurology|December 14, 2005
Postischemic infusion of adrenomedullin protects against ischemic stroke by inhibiting apoptosis and promoting angiogenesisChun-Fang Xia, Hang Yin, Cesar V Borlongan, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 24, 2013
Tissue kallikrein-modified mesenchymal stem cells provide enhanced protection against ischemic cardiac injury after myocardial infarctionLin Gao, Grant Bledsoe, Hang Yin, et al.
American Journal of Physiology. Renal Physiology|July 20, 2012
Depletion of endogenous kallistatin exacerbates renal and cardiovascular oxidative stress, inflammation, and organ remodelingYuying Liu, Grant Bledsoe, Makato Hagiwara, et al.
Pageof 11